Skip to content
ChickenStockChickenStock
ResearchPGNY
Progyny logo

Progyny (PGNY) stock

NASDAQ

$36.70-1.21%(-0.45)

As of the Nov 17, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

29.85x

P/B

6.56x

P/S

2.03x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 8.9% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 5, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

37 SEC filings
  • Clapp GeoffreyChief Product Officer · Nov 11, 2026Open-market sale774 shares · $28K
    Avg. price $36.4158,235 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Nov 10, 2026Open-market sale236,630 shares · $8.5M
    Avg. price $35.8446
    Show 4 price lots
    • 120,213 shares × $35.6068$4.3M
    • 64,921 shares × $36.2851$2.4M
    • 33,437 shares × $35.6067$1.2M
    • 18,059 shares × $36.2851$655K
  • Schlanger David JExecutive Chairman · Nov 10, 2026Open-market sale35,392 shares · $1.3M
    Avg. price $35.3613238,462 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Nov 10, 2026Option exercise185,134 shares · $168K
    Avg. price $0.91947,602 shares held after
  • Schlanger David JExecutive Chairman · Nov 10, 2026Option exercise35,392 shares · $32K
    Avg. price $0.91273,854 shares held after
  • Schlanger David JExecutive Chairman · Nov 9, 2026Open-market sale161,208 shares · $5.8M
    Avg. price $35.7263238,462 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Nov 9, 2026Open-market sale161,308 shares · $5.8M
    Avg. price $35.7257
    Show 2 price lots
    • 126,204 shares × $35.7257$4.5M
    • 35,104 shares × $35.7257$1.3M
  • Schlanger David JExecutive Chairman · Nov 9, 2026Option exercise161,208 shares · $147K
    Avg. price $0.91399,670 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Nov 9, 2026Option exercise126,204 shares · $115K
    Avg. price $0.91923,776 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Nov 5, 2026Open-market sale11,939 shares · $419K
    Avg. price $35.1296
    Show 2 price lots
    • 8,539 shares × $35.0906$300K
    • 3,400 shares × $35.2276$120K
  • Schlanger David JExecutive Chairman · Nov 5, 2026Open-market sale3,400 shares · $120K
    Avg. price $35.2209238,462 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Nov 5, 2026Option exercise3,400 shares · $3K
    Avg. price $0.91809,511 shares held after
  • Schlanger David JExecutive Chairman · Nov 5, 2026Option exercise3,400 shares · $3K
    Avg. price $0.91241,862 shares held after
  • Livingston Mark S.CHIEF FINANCIAL OFFICER · Nov 4, 2026Open-market sale2,139 shares · $64K
    Avg. price $3070,314 shares held after
  • Swartz AllisonEVP, GC · Nov 2, 2026Grant or award8,160 shares · $0
    Avg. price $083,976 shares held after
  • Cummings Melissa BChief Operating Officer · Oct 14, 2026Open-market sale1,879 shares · $53K
    Avg. price $2866,496 shares held after
  • Cummings Melissa BChief Operating Officer · Oct 14, 2026Shares withheld for taxes1,559 shares · $43K
    Avg. price $27.3968,375 shares held after
  • Swartz AllisonEVP, GC · Sep 23, 2026Open-market sale3,903 shares · $102K
    Avg. price $26.175,816 shares held after
  • Clapp GeoffreyChief Product Officer · Sep 17, 2026Shares withheld for taxes819 shares · $22K
    Avg. price $27.3859,009 shares held after
  • GORDON KEVIN KDirector · Sep 10, 2026Open-market sale23,000 shares · $633K
    Avg. price $27.53116,792 shares held after
    Show 2 price lots
    • 11,500 shares × $27.9442$321K
    • 11,500 shares × $27.1181$312K
  • GORDON KEVIN KDirector · Sep 10, 2026Shares withheld for taxes21,000 shares · $572K
    Avg. price $27.2418,292 shares held after
    Show 2 price lots
    • 10,500 shares × $27.24$286K
    • 10,500 shares × $27.24$286K
  • GORDON KEVIN KDirector · Sep 10, 2026Option exercise44,000 shares · $572K
    Avg. price $1328,792 shares held after
    Show 2 price lots
    • 22,000 shares × $13$286K
    • 22,000 shares × $13$286K
  • Livingston Mark S.CHIEF FINANCIAL OFFICER · Sep 4, 2026Shares withheld for taxes479 shares · $13K
    Avg. price $26.6172,453 shares held after
  • Swartz AllisonEVP, GC · Sep 4, 2026Shares withheld for taxes479 shares · $13K
    Avg. price $26.6179,719 shares held after
  • Anevski PeterCHIEF EXECUTIVE OFFICER · Sep 3, 2026Shares withheld for taxes5,361 shares · $141K
    Avg. price $26.29806,111 shares held after
  • Livingston Mark S.CHIEF FINANCIAL OFFICER · Sep 3, 2026Shares withheld for taxes1,532 shares · $40K
    Avg. price $26.2972,932 shares held after
  • Swartz AllisonEVP, GC · Sep 3, 2026Shares withheld for taxes828 shares · $22K
    Avg. price $26.2980,198 shares held after
  • Livingston Mark S.CHIEF FINANCIAL OFFICER · Sep 2, 2026Shares withheld for taxes224 shares · $6K
    Avg. price $25.6674,464 shares held after
  • Swartz AllisonEVP, GC · Aug 28, 2026Shares withheld for taxes1,352 shares · $35K
    Avg. price $25.8681,026 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Progyny (PGNY) stock information

NASDAQ

Progyny (PGNY) is listed on NASDAQ. Its market capitalization is about $2.7B. On trailing-twelve-month earnings the P/E ratio is 29.85, and the P/B ratio is 6.56. Return on equity is 22%. These figures are computed in-house from official filings and are reference information only.

Progyny — frequently asked questions

What is the P/E ratio of Progyny (PGNY)?
On a trailing-twelve-month basis, PGNY trades at a P/E ratio of 29.85. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Progyny?
PGNY has a market capitalization of about $2.7B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.